[PDF][PDF] Number needed to treat (NNT) and cost of preventing an event (COPE) analysis for pembrolizumab in non-squamous metastatic non–small-cell lung cancer …
V Wurcel, J Urrego-Reyes, COL Vinueza - Population - ispor.org
Number needed to treat (NNT) and cost of preventing an event (COPE) analysis for
pembrolizumab in non-squamous metastatic non– Page 1 Victoria Wurcel1; Juan Urrego-Reyes2; …
pembrolizumab in non-squamous metastatic non– Page 1 Victoria Wurcel1; Juan Urrego-Reyes2; …